- Home
- MNKD vs LION Comparison
MNKD vs LION Comparison
Compare MNKD & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- LION
- Stock Information
- Founded
- MNKD 1991
- LION 1997
- Country
- MNKD United States
- LION United States
- Employees
- MNKD N/A
- LION N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- LION Movies/Entertainment
- Sector
- MNKD Health Care
- LION Consumer Discretionary
- Exchange
- MNKD Nasdaq
- LION Nasdaq
- Market Cap
- MNKD 1.7B
- LION 2.0B
- IPO Year
- MNKD 2004
- LION N/A
- Fundamental
- Price
- MNKD $5.33
- LION $6.50
- Analyst Decision
- MNKD Strong Buy
- LION Buy
- Analyst Count
- MNKD 5
- LION 9
- Target Price
- MNKD $10.80
- LION $8.88
- AVG Volume (30 Days)
- MNKD 4.4M
- LION 2.2M
- Earning Date
- MNKD 11-05-2025
- LION 11-06-2025
- Dividend Yield
- MNKD N/A
- LION N/A
- EPS Growth
- MNKD 149.32
- LION N/A
- EPS
- MNKD 0.11
- LION N/A
- Revenue
- MNKD $301,736,000.00
- LION $3,986,900,000.00
- Revenue This Year
- MNKD $14.78
- LION N/A
- Revenue Next Year
- MNKD $19.36
- LION $21.07
- P/E Ratio
- MNKD $50.09
- LION N/A
- Revenue Growth
- MNKD 21.48
- LION 10.89
- 52 Week Low
- MNKD $3.38
- LION $5.55
- 52 Week High
- MNKD $7.63
- LION $8.50
- Technical
- Relative Strength Index (RSI)
- MNKD 49.48
- LION 54.15
- Support Level
- MNKD $5.28
- LION $5.88
- Resistance Level
- MNKD $5.62
- LION $6.59
- Average True Range (ATR)
- MNKD 0.24
- LION 0.25
- MACD
- MNKD -0.02
- LION 0.05
- Stochastic Oscillator
- MNKD 58.80
- LION 87.41
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.